Anti-angiogenic effects of pterogynidine alkaloid isolated from Alchornea glandulosa

BMC Complementary and Alternative Medicine

Volumn 9, Issue , 2009, Pages

  Lopes, Flávia C M ^a   Rocha, Ana ^b   Pirraco, Ana ^b   Regasini, Luis O ^a   Silva, Dulce H S ^a   Bolzani, Vanderlan S ^a   Azevedo, Isabel ^b   Carlos, Iracilda Z ^a   Soares, Raquel ^b  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b University of Porto   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALOID; ANGIOGENESIS INHIBITOR; BROXURIDINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MATRIGEL; PTEROGYNIDINE; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; GUANIDINE DERIVATIVE; PLANT EXTRACT;

ALCHORNEA GLANDULOSA; ANTIANGIOGENIC ACTIVITY; APOPTOSIS; ARTICLE; CELL CULTURE; CELL INVASION; CELL LINE; CELL LINE HUVEC; CELL VIABILITY; CONTROLLED STUDY; DRUG STRUCTURE; GENE ACTIVITY; GENE EXPRESSION; HUMAN; HUMAN CELL; NICK END LABELING; PLANT; ANALYSIS OF VARIANCE; CANCER INVASION; CELL PROLIFERATION; CHEMISTRY; DRUG ANTAGONISM; DRUG EFFECT; ENDOTHELIUM CELL; EUPHORBIA; ISOLATION AND PURIFICATION; MEDICINAL PLANT; PLANT LEAF; UMBILICAL VEIN;

ALKALOIDS; ANALYSIS OF VARIANCE; ANGIOGENESIS INHIBITORS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CELL LINE; CELL PROLIFERATION; ENDOTHELIAL CELLS; EUPHORBIACEAE; GUANIDINES; HUMANS; IN SITU NICK-END LABELING; NEOPLASM INVASIVENESS; NF-KAPPA B; PLANT EXTRACTS; PLANT LEAVES; PLANTS, MEDICINAL; UMBILICAL VEINS;

EID: 67651166854     PISSN: None     EISSN: 14726882     Source Type: Journal    
DOI: 10.1186/1472-6882-9-15     Document Type: Article

References (53)

1. Folkman J Angiogenesis in cancer, vascular, rheumatoid and other disease Nat Med 1995, 1:27-31 7584949
2. Costa C Incio J Soares R Angiogenesis and chronic inflammation: Cause or consequence? Angiogenesis 2007, 10:149-166 17457680
3. Fayette J Soria JC Armand JP Use of angiogenesis inhibitors in tumour treatment Eur J Cancer 2005, 41:1109-1116 15911233
4. Giavazzi R Taraboletti G Angiogenesis and angiogenesis inhibitors in cancer Forum (Genova) 1999, 9:261-272 10504172
5. Gately S Li WW Multiple roles of COX-2 in tumor angiogenesis: A target for antiangiogenic therapy Semin Oncol 2004, 31:2-11 15179620
6. El Sayed KA Natural products as angiogenesis modulators Mini Rev Med Chem 2005, 5:971-993 16307528
7. Prat A Casado E Cortés J New approaches in angiogenic targeting for colorectal cancer World J Gastroenterol 2007, 13:5857-5866 17990351
8. Gordaliza M Natural products as leads to anticancer drugs Clin Transl Oncol 2007, 9:767-776 18158980
9. Younes RN Varella AD Suffredii IB Discovery of new antitumoral and antibacterial drugs from brazilian plant extracts using high throughput screening Clinics 2007, 62:763-768 18318049
10. Suffredini IB Varella AD Younes RN Cytotoxic molecules from natural sources: Tapping the Brazilian biodiversity Anticancer Agents Med Chem 2006, 6:367-375 16842236
11. Suffredini IB Paciencia ML Varella AD Younes RN In vitro cytotoxic activity of Brazilian plant extracts against human lung, colon and CNS solid cancers and leukemia Fitoterapia 2007, 78:223-226 17346903
12. Kutchan TM Alkaloid biosynthesis [mdash] the Basis for metabolic engineering of medicinal plants Plant Cell 1995, 7:1059-1070 160910 12242397
13. Ram VJ Kumari S Natural products of plant origin as anticancer agents Drug News Perspect 2001, 14:465-482 12806432
14. Oberlies NH Kroll DJ Camptothecin and taxol: Historic achievements in natural products research J Nat Prod 2004, 67:129-135 14987046
15. Kingston DG Newman DJ Taxoids: Cancer-fighting compounds from nature Curr Opin Drug Discov Devel 2007, 10:130-144 17436548
16. Williams JE Review of antiviral and immunomodulating properties of plants of the peruvian rainforest with a particular emphasis on uña de gato and sangre de grado Altern Med Rev 2001, 6:567-579 11804547
17. Kantarjian HM O'Brien S Anderlini P Talpaz M Treatment of myelogenous leukemia: Current status and investigational options Blood 1996, 87:3069-3081 8605319
18. Bolzani VS Gunatilaka AAL Kingston DGI Bioactive guanidine alkaloids from Pterogyne nitens J Nat Prod 1995, 58:1683-1688
19. Lorenzi H Árvores Brasileiras: Manual de identificação e cultivo de plantas e árvores nativas do Brasil Nova Odessa: Plantarum 1998
20. Lopes FC Calvo TR Vilegas W Carlos IZ Inhibition of hydrogen peroxide, nitric oxide and TNF-alpha production in peritoneal macrophages by ethyl acetate fraction from Alchornea glandulosa Biol Pharm Bull 2005, 28:1726-1730 16141548
21. Guerreiro S Monteiro R Martins MJ Calhau C Azevedo I Soares R Distinct modulation of alkaline phosphatase isoenzymes by 17beta-estradiol and xanthohumol in breast cancer MCF-7 cells Clin Biochem 2007, 40:268-273 17126313
22. Soares R Guo S Russo J Schmitt FC Role of the estrogen antagonist ICI182, 780 in vessel assembly and apoptosis of endothelial cells Ultrastruct Pathol 2003, 27:33-39 12554534
23. Soares R Balogh G Guo S Gartner F Russo J Schmitt F Evidence for the notch signaling pathway on the role of estrogen in angiogenesis Mol Endocrinol 2004, 18:2333-2343 15192074
24. Monteiro R Calhau C Guerreiro S Gartner F Oliveira e Silva A Pinheiro-Silva S Azevedo I Soares R Xanthohumol inhibits inflammatory factor production and angiogenesis in breast cancer xenografts J Cell Biochem 2008, 104:1699-1707 18348194
25. Magne N Toillon RA Bottero V Didelot C Houtte PV Gérard JP Peyron JF NF-(kappa)B modulation and ionizing radiation: Mechanisms and future directions for cancer treatment Cancer Lett 2006, 231:158-168 16399220
26. Quesada AR Muñoz-Chápuli R Medina MA Anti-angiogenic drugs: from bench to clinical trials Med Res Rev 2006, 26:483-530 16652370
27. Miller KD Sweeney CJ Sledge GW Jr Redefining the target: chemotherapeutics as antiangiogenics J Clin Oncol 2001, 19:1195-1206 11181686
28. Tan G Gyllenhaal C Soejarto DD Biodiversity as a source of anticancer drugs Curr Drug Targets 2006, 7:265-277 16515527
29. Loboda A Cisowski J Zarebski A Ja wa A Riviera Nunez D Kypriotakis Z Heinrich M Dulak J Effects of plant extracts on angiogenic activities of endothelial cells and keratinocytes J Physiol Pharmacol 2005, 56:125-137 15800390
30. Neal CP Berry DP Doucas H Manson MM Steward W Garcea G Clinical aspects of natural anti-angiogenic drugs Curr Drug Targets 2006, 7:371-383 16555420
31. Ribatti D Guidolin D Conconi MT Nico B Baiguera S Parnigotto PP Vacca A Nussdorfer GG Vinblastine inhibits the angiogenic response induced by adrenomedullin in vitro and in vivo Oncogene 2003, 22:6458-6461 14508526
32. Eun JP Koh GY Suppression of angiogenesis by the plant alkaloid, sanguinarine Biochem Biophys Res Commun 2004, 317:618-624 15063803
33. Kruczynski A Poli M Dossi R Chazottes E Berrichon G Ricome C Giavazzi R Hill BT Taraboletti G Anti-angiogenic, vascular-disrupting and anti-metastatic activities of vinflunine, the latest vinca alkaloid in clinical development Eur J Cancer 2006, 42:2821-2832 16973349
34. Basini G Bussolati S Santini SE Grasselli F Sanguinarine inhibits VEGF-induced angiogenesis in a fibrin gel matrix Biofactors 2007, 29:11-18 17611290
35. Elkin M Miao HQ Nagler A Aingorn E Reich R Hemo I Dou HL Pines M Vlodavsky I Halofuginone: A potent inhibitor of critical steps in angiogenesis progression FASEB J 2000, 14:2477-2485 11099465
36. Nor JE Polverini PJ Role of endothelial cell survival and death signals in angiogenesis Angiogenesis 1999, 3:101-116 14517428
37. Cheng AC Jian CB Huang YT Lai CS Hsu PC Pan MH Induction of apoptosis by Uncaria tomentosa through reactive oxygen speciesproduction, cytochrome c release, and caspases activation in human leukemia cells Food Chem Toxicol 2007, 45:2206-2218 17619071
38. Pilarski R Poczekaj-Kostrzewska M Ciesio ka D Szyfter K Gulewicz K Antiproliferative activity of various Uncaria tomentosa preparations on HL-60 promyelocytic leukemia cells Pharmacol Rep 2007, 59:565-572 18048957
39. Mavar-Manga H Haddad M Pieters L Baccelli C Penge A Quetin-Leclercq J Anti-inflammatory compounds from leaves and root bark of Alchornea cordifolia (Schumach. & Thonn.) Müll. Arg J Ethnopharmacol 2008, 115:25-29 17942256
40. Mavar-Manga H Chapon D Hoet S Block S Pauw-Gillet MC Quetin-Leclercq J N1, N2, N3-trisisopentenyl guanidine and N1, N2-diisopentenyl guanidine, two cytotoxic alkaloids from Alchornea cordifolia (Schumach. & Thonn.) Mull. Arg. (Euphorbiaceae) root barks Nat Prod Commun 2006, 1:1097-1100
41. Buchanan B Gruissem W Jones R Biochemistry & molecular biology of plants Natural products (secondary metabolites) New York: Wiley-Liss Croteau R, Kutchan TM, Lewis NG 2002:1250-1318
42. Bouaicha N Amade P Puel D Roussakis C Zarzissine, a new cytotoxic guanidine alkaloid from the Mediterranean sponge Anchinoe paupertas J Nat Prod 1994, 57(10):1455-1457 7807130
43. Chang L Whittaker NF Bewley CA Crambescidin 826 and dehydrocrambine A: new polycyclic guanidine alkaloids from the marine sponge Monanchora sp that inhibit HIV-1 fusion J Nat Prod 2003, 66:1490-1494 14640525
44. Sorek H Rudi A Gueta S Reyes F Martin MJ Aknin M Gaydou E Vacelet J Kashman Y Netamines A-G: Seven new tricyclic guanidine alkaloids from the marine sponge Biemna laboutei Tetrahedron 2006, 62:8838-8843
45. Kok TW Yue PY Mak NK Fan TP Liu L Wong RN The anti-angiogenic effect of sinomenine Angiogenesis 2005, 8:3-12 16132613
46. Sagar SM Yance D Wong RK Natural health products that inhibit angiogenesis: A potential source for investigational new agents to treat cancer - Part 1 Curr Oncol 2006, 13:14-26 1891166 17576437
47. Lee CH Jeon YT Kim SH Song YS NF-kappaB as a potential molecular target for cancer therapy Biofactors 2007, 29:19-35 17611291
48. Ichikawa H Nakamura Y Kashiwada Y Aggarwal BB Anticancer drugs designed by mother nature: Ancient drugs but modern targets Curr Pharm Des 2007, 13:3400-3416 18045194
49. Tosetti F Ferrari N De Flora S Albini A Angioprevention: Angiogenesis is a common and key target for cancer chemopreventive agents FASEB J 2002 ,16:2-14 11772931
50. Noonan DM Benelli R Albini A Angiogenesis and cancer prevention: A vision Recent Results Cancer Res 2007, 174:219-224 17302199
51. Singh S Khar A Biological effects of curcumin and its role in cancer chemoprevention and therapy Anticancer Agents Med Chem 2006, 6:259-270 16712454
52. Mohan R Hammers H Bargagna-Mohan P Zhan X Herbstritt C Ruiz A Zhang L Hanson A Conner B Rougas J Pribluda V Withaferin A is a potent inhibitor of angiogenesis Angiogenesis 2004, 7:115-122 15516832
53. Mojzis J Varinska L Mojzisova G Kostova I Mirossay L Antiangiogenic effects of flavonoids and chalcones Pharmacol Res 2008, 57:259-265 18387817